Nosenzo John 4
4 · Bioventus Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Nosenzo John
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-02-11−1,470→ 0 total→ Class A Common Stock (1,470 underlying) - Sale
Class A Common Stock
2022-02-14$11.99/sh−534$6,401→ 43,370 total - Exercise/Conversion
Class A Common Stock
2022-02-11+1,470→ 43,904 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 11, 2022 pursuant to a standing 10b5-1 instruction.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.87 to $11.99, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The restricted stock units vested on February 11, 2022.